Valuation : INVO Fertility, Inc.

Market Cap 1.76M 1.51M 1.42M 1.3M 2.43M 166M 2.44M 16.8M 6.52M 85.08M 6.6M 6.45M 274M P/E 2026 *
-0.04x
P/E 2027 * -0.12x
Enterprise Value 1.76M 1.51M 1.42M 1.3M 2.43M 166M 2.44M 16.8M 6.52M 85.08M 6.6M 6.45M 274M EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.11x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+0.16%
1 week-1.50%
Current month-4.37%
1 month-6.19%
3 months-40.66%
6 months-77.78%
Current year-73.82%
1 week 0.97
Extreme 0.9701
1.04
1 month 0.95
Extreme 0.954
2.8
Current year 0.9
Extreme 0.9001
22.9
1 year 0.9
Extreme 0.9001
84.4
3 years 0.9
Extreme 0.9001
1,785.46
5 years 0.9
Extreme 0.9001
1,785.46
10 years 0.9
Extreme 0.9001
1,785.46
Date Insider Type Main position Quantity % Market Cap. Importance
30/12/25 Other

Chief Financial Officer

4,399 0.2326%
03/12/25 Sell

Director

7 0.0004%
26/08/25 Other

Director

45,000 4.8477%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%-1.50%-97.08% - 1.76M
-0.42%-3.68%-18.43%+7.39% 188B
+1.15%+3.22%+1.42%+17.42% 119B
-1.86%+2.77%+13.07%+91.44% 64.35B
-1.31%-1.33%+23.64%+48.69% 52.59B
-1.54%-2.52%-3.41%-32.30% 51.11B
-2.02%-3.22%+8.84%-12.39% 33.85B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+37.34%-15.78% 24.12B
-1.44%-5.00%-7.60%+9.97% 23.39B
Average -0.91%-0.37%-4.69%+14.31% 58.89B
Weighted average by Cap. -0.71%-0.57%-0.66%+17.41%

Financials

2026 *2027 *
Net sales 10.42M 8.97M 8.44M 7.71M 14.41M 984M 14.45M 99.68M 38.68M 505M 39.12M 38.27M 1.63B 16.46M 14.16M 13.33M 12.17M 22.77M 1.55B 22.84M 157M 61.11M 797M 61.81M 60.46M 2.57B
Net income -5.44M -4.68M -4.41M -4.03M -7.53M -514M -7.55M -52.07M -20.21M -264M -20.44M -19.99M -849M -3.03M -2.6M -2.45M -2.24M -4.19M -286M -4.2M -28.95M -11.23M -147M -11.36M -11.12M -472M
Net Debt - -
Logo INVO Fertility, Inc.
INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, profitable in vitro fertilization (IVF) clinics. The Company has four operational fertility clinics in the United States. The Company is also engaged in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments.
Employees
-
Date Price Change Volume
05/09/26 $0.9850 +0.16% 185,052
03/09/26 $0.9834 -2.63% 218,088
02/09/26 $1.010 0.00% 124,947
01/09/26 $1.010 -1.94% 244,647
31/08/26 $1.030 +3.00% 184,852
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.9834USD
Average target price
20.00USD
Spread / Average Target
+1,933.76%

Quarterly revenue - Rate of surprise